
Cyclacel Pharmaceuticals, Inc.
CYCCP
|
NASDAQ
|
0 Sledující
Company Quality
Profitability Score
50/100
Solvency Score
75/100
Dividends
$0.15
Dividend Amount
3.00%
Dividend Yield
in 43 days
Next ex-date
in 54 days
Next payment date
Earnings
8/12/2025
in 65 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Sing Ee Wong
CEO
12
Zaměstnanci
Berkeley Heights
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$8.2MEnterprise Value
$4.8MPrice to Earnings
-0.31Price to Sales
-392.4Price to Book
0.65Price to Cash Flow
-1.10Profitability
Return on Assets
-168.96%Return on Equity
-2,752.03%Return on Invested Capital
-267.59%Gross Margin
128.57%Operating Margin
36,423.80%Net Margin
30,043.00%Liquidity
Quick Ratio
5.60Current Ratio
5.60Cash Ratio
5.20Inventory Turnover
0.00Asset Turnover
-0.0056Total Liabilities
$672Solvency
Debt to Assets
0.0024Debt to Equity
N/AInterest Coverage
-273.2Equity Ratio
0.82Long-term Debt to Cap.
0.00Altman Z-Score
25,261Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.